High materiality8/10
Relay Therapeutics price target raised to $30 from $27 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays lifts RLAY target to $30; current price $19.75; suggests ~52% upside based on new target.
- Barclays lifts target to $30; price $19.75; ~52% upside.
Key facts
- 01
Target: $30
- 02
Posted price: $19.75
- 03
Analyst firm: Barclays
- 04
Analyst: Etzer Darout
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.